NR-AXIAL SPONDYLOARTHRITIS

Clinical trials for NR-AXIAL SPONDYLOARTHRITIS explained in plain language.

Never miss a new study

Get alerted when new NR-AXIAL SPONDYLOARTHRITIS trials appear

Sign up with your email to follow new studies for NR-AXIAL SPONDYLOARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug shows promise for Hard-to-Treat back pain

Disease control Not yet recruiting

This study tests a new drug called xeligekimab for people with non-radiographic axial spondyloarthritis, a condition that causes long-term back pain and stiffness. About 40 adults who have not responded well to standard anti-inflammatory drugs will receive injections of xeligekim…

Matched conditions: NR-AXIAL SPONDYLOARTHRITIS

Phase: PHASE2, PHASE3 • Sponsor: Lingli Dong • Aim: Disease control

Last updated May 08, 2026 12:03 UTC

NR-AXIAL SPONDYLOARTHRITIS

Get alerted when new NR-AXIAL SPONDYLOARTHRITIS trials appear

New drug shows promise for Hard-to-Treat back pain